The northeastern part of the United States is approaching the annual
respiratory syncytial virus (RSV) season, which is November 2017 through March
2018. RSV is the most common cause of bronchiolitis and pneumonia among
children younger than one year. During RSV season, Independence will approve
the monthly administration of Synagis® for children in
accordance with the most recent recommendations from the American Academy of
Pediatrics (AAP).
It is mandatory for all participating providers to obtain
Synagis® through ACRO Pharmaceutical Services, an independent
company.
In October, detailed information about how to order Synagis®,
as well as the complete list of recommendations for Synagis®
from the AAP, will be communicated via Partners in Health
UpdateSM. If you have questions about the
Synagis® distribution program, please contact Customer Service
at 1-800-ASK-BLUE.
This is not a statement of benefits. Benefits may vary
based on state requirements, Benefits Program (HMO, PPO, etc.), and/or employer
groups. Providers should use the NaviNet® web portal to view the
member?s applicable benefits information. Members should be instructed to call
the Customer Service telephone number listed on their ID card.
NaviNet is a registered trademark of NaviNet, Inc., an
independent company.